IL6 and Alzheimer disease: Post hoc analysis determined that cortical IL-6 was significantly reduced in 3xTg-AD mice receiving fingolimod compared to vehicle controls (Veh: 2.424 ± 0.13, FTY: 1.881 ± 0.15; p = 0.0182, n = 5–6).